| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Current estimates from the National Health Interview Survey, 1996.
|
Vital Health Stat 10
|
1999
|
2.81
|
|
2
|
The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans.
|
J Clin Invest
|
1990
|
2.08
|
|
3
|
IL-8 in septic shock, endotoxemia, and after IL-1 administration.
|
J Immunol
|
1991
|
2.03
|
|
4
|
Current estimates from the National Health Interview Survey, 1992.
|
Vital Health Stat 10
|
1994
|
1.95
|
|
5
|
Current estimates from the National Health Interview Survey, 1995.
|
Vital Health Stat 10
|
1998
|
1.95
|
|
6
|
Total parenteral nutrition and bowel rest modify the metabolic response to endotoxin in humans.
|
Ann Surg
|
1989
|
1.79
|
|
7
|
Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man.
|
J Immunol
|
1993
|
1.73
|
|
8
|
Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia.
|
J Clin Invest
|
1992
|
1.58
|
|
9
|
Splanchnic bed utilization of leucine and phenylalanine in humans.
|
Am J Physiol
|
1993
|
1.35
|
|
10
|
Current estimates from the National Health Interview Survey, 1994.
|
Vital Health Stat 10
|
1995
|
1.33
|
|
11
|
Peripheral blood leukocyte kinetics following in vivo lipopolysaccharide (LPS) administration to normal human subjects. Influence of elicited hormones and cytokines.
|
Ann Surg
|
1989
|
1.27
|
|
12
|
Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo.
|
FASEB J
|
1989
|
1.17
|
|
13
|
Comparison between effects of interleukin-1 alpha administration and sublethal endotoxemia in primates.
|
Am J Physiol
|
1991
|
1.12
|
|
14
|
Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease.
|
Blood
|
1992
|
1.07
|
|
15
|
Splanchnic bed utilization of glutamine and glutamic acid in humans.
|
Am J Physiol
|
1993
|
1.03
|
|
16
|
Current estimates from the National Health Interview Survey, 1994.
|
Vital Health Stat 10
|
1995
|
1.02
|
|
17
|
Tolerance to endotoxin prevents mortality in infected thermal injury: association with attenuated cytokine responses.
|
J Infect Dis
|
1992
|
1.02
|
|
18
|
The decrease in peripheral blood CD4+ T cells following thermal injury in humans can be accounted for by a concomitant decrease in suppressor-inducer CD4+ T cells as assessed using anti-CD45R.
|
Clin Immunol Immunopathol
|
1988
|
0.96
|
|
19
|
Hepatocellular membrane function during chronic burn injury.
|
J Surg Res
|
1989
|
0.90
|
|
20
|
Identification of a novel tumor necrosis factor alpha/cachectin from the livers of burned and infected rats.
|
Arch Surg
|
1990
|
0.87
|
|
21
|
Comparison of peripheral blood leukocyte kinetics after live Escherichia coli, endotoxin, or interleukin-1 alpha administration. Studies using a novel interleukin-1 receptor antagonist.
|
Ann Surg
|
1993
|
0.82
|
|
22
|
Whole body and splanchnic leucine, phenylalanine, and glucose kinetics during endotoxemia in humans.
|
Am J Physiol
|
1994
|
0.81
|
|
23
|
Skeletal muscle amino acid and myofibrillar protein mRNA response to thermal injury and infection.
|
Am J Physiol
|
1991
|
0.80
|
|
24
|
Resuscitation of the thermally injured patient.
|
Crit Care Clin
|
1992
|
0.75
|
|
25
|
Starvation leads to decreased levels of mRNA for myofibrillar proteins.
|
J Surg Res
|
1989
|
0.75
|
|
26
|
Pediatric burns. An overview.
|
Pediatr Clin North Am
|
1992
|
0.75
|
|
27
|
Pain and anxiety with burn dressing changes: patient self-report.
|
J Burn Care Rehabil
|
2000
|
0.75
|